China NMPA Drug Inspection - Shanghai Qingpu Traditional Chinese Medicine Pieces Co., Ltd. - Magnolia officinalis flower
China NMPA drug inspection for Shanghai Qingpu Traditional Chinese Medicine Pieces Co., Ltd. published September 04, 2019. Drug: Magnolia officinalis flower. The Shanghai Municipal Drug Administration announced on September 4, 2019, the results of its 2019 drug quality sampling
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Shanghai Qingpu Traditional Chinese Medicine Pieces Co., Ltd. published September 04, 2019. Drug: Magnolia officinalis flower. The Shanghai Municipal Drug Administration announced on September 4, 2019, the results of its 2019 drug quality sampling
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox